Objectives: To describe the use and reporting of interrupted time series methods in drug utilization research. Study Design and Setting: We completed a systematic search of MEDLINE, Web of Science, and reference lists to identify English language articles through to December 2013 that used interrupted time series methods in drug utilization research. We tabulated the number of studies by publication year and summarized methodological detail.
Introduction
Interrupted time series analysis is the strongest and most commonly used quasi-experimental design to assess the impact of an intervention when a randomized controlled trial is not feasible [1e6] . This method has been applied in a variety of disciplines and was first introduced to the field of health services research in 1981 to evaluate the impact of regionalized perinatal care [7] . Interrupted time series methods use aggregate data collected over equally spaced intervals before and after an intervention, with the key assumption that data trends before the intervention can be extrapolated to predict trends had the intervention not occurred [3] . Routinely maintained pharmacy and medical databases provide rich data sources to apply interrupted time series methods [3] .
Several methodological issues need to be considered when completing an interrupted time series analysis. First,
What is new?
There has been an increase in the application of interrupted time series analysis in drug utilization research, particularly in recent years.
We identified large variation in methodological considerations reported in empirical applications.
Developing methodological and reporting standards for interrupted time series analysis is important to improve its application in drug utilization research, and we provide recommendations for consideration.
given the serial nature of the design, autocorrelation, nonstationarity, and seasonality need to be considered [3, 8] . Autocorrelation refers to the serial dependence of outcome measure error terms. For example, prescription patterns closer to each other may be more similar than those further apart [3, 5, 6] . The presence of autocorrelation can be assessed using the LjungeBox chi-square statistic [9] or DurbineWatson statistic [3, 5, 6, 10] and corrected for if necessary. Nonstationary data exhibit an underlying trend that is unrelated to the intervention. For example, the use of a drug commonly increases once it enters the market [8] . Nonstationary can be tested using the augmented DickeyeFuller test [11] . Seasonality represents regular seasonal fluctuations in the outcome, for example, use of medications to treat influenza. When present, terms for seasonality (e.g., months) should be included in the model [3, 6] . Failing to account for autocorrelation, nonstationarity, and seasonality may lead to biased results.
The number of data points available for analysis and the number of observations within each data point are important when using interrupted time series analysis. Although there is no gold standard, it is generally agreed that more data points and observations are better. Depending on the minimum effect size and the amount of variation, a minimum of nine data points preintervention, postintervention, and when applicable, between interventions [4, 12] , and at least 100 observations per data point is encouraged [3] . A larger number of observations in each data point provides more stable estimates and thus reduces the variability and outliers within a time series analysis. Data point outliers that are explainable, such as a sudden peak in drug dispensing in anticipation of a drug restriction policy, can be controlled for using an indicator term [3] . Outliers that result from random variation can be treated as regular data points [3] . A larger number of data points also permit more stable estimates for forecasting preintervention trends had the intervention not occurred. In general, however, caution should be used when forecasting beyond the data points observed in interrupted time series analyses. Another caveat when conducting interrupted time series analysis relates to possible outcome measure ceiling or floor effects. For example, when studying the impact of an intervention in improving the proportion of patients treated with a drug, the outcome has a natural ceiling of 100%, and thus, depending on the initial level of measurement, minimal change in the outcome may be observed [13] . Authors must consider ceiling and floor effects when designing their study and interpreting results.
A clear intervention time point helps to identify preintervention and postintervention data points, yet if intervention effects are gradual or delayed, then a lag period may be considered [3] . Lagged intervention effects can be accounted for by excluding the lag period from the analysis, modeling the lag period as a separate segment in the time series [3] , or using a ramp function in autoregressive integrated moving average (ARIMA) models [14] . Here, graphical figures displaying the results of interrupted time series analysis are particularly useful. Even without statistical output, figures allow readers to visually examine baseline trends, the time point at which the intervention occurred, and the impact of the intervention [3, 5] . All interrupted time series studies should therefore include graphical display to facilitate interpretation of study results.
The main threat to validity in interrupted time series analysis relates to time-varying confounding, such as changes in outcome coding, cointerventions, or changes in the population under study [3e5,15] . These threats need to be considered at the individual study level and require intimate knowledge of the data and health care utilization trends. The use of a comparison outcome in the same population, or a comparison group using the same outcome in a group not exposed to the intervention, helps to alleviate concerns related to time-varying confounding [3, 5] . Indeed, an advantage of interrupted time series analysis is the ease in stratifying results by different groups [5] .
Interrupted time series analysis has been applied in a variety of disciplines; however, its use to study the impact of health care interventions on drug utilization has not been well described. The purpose of our study was to describe the use and reporting of interrupted time series methods in drug utilization research.
Methods
We completed a systematic MEDLINE keyword and Web of Science citation search to identify all English language articles that used interrupted time series methods to study drug utilization in humans. Empirical applications that examined the impact of interventions at the population level, including drug policy changes, new evidence in the form of guideline changes or major publications, quality improvement interventions, and government or media safety advisories; on prescription drug utilization were eligible. We defined drug utilization as the number or proportion of drug(s) dispensed, patients dispensed a drug, or patients meeting an adherence target. Systematic reviews, methodological contributions, letters to the editor, and conference abstracts were excluded because the focus was on use and reporting of empirical applications. We also excluded single institution studies so we could focus on population-based interventions that may be more generalizable.
We first searched MEDLINE from inception (1946) to December 2013 with keyword terms related to time series analysis and drug utilization (Appendix A at www.jclinepi. com). We then used Web of Science to perform a citation search of methodological articles identified in the keyword search [3, 5, 16] and a commonly cited article [7] . We abstracted the following characteristics for each application: intervention(s) of interest, primary data source, and methodological detail (time intervals, outcome measure, interrupted time series methods used, and methodological considerations reported). As previously described, there are several methodological considerations in interrupted time series analysis, and we have taken care to abstract whether authors reported these; however, we were unable to evaluate aspects that would require access to each study's raw data. Thus, methodological considerations abstracted included reporting of autocorrelation, nonstationarity, and seasonality; use of a comparison group; clearly defined time points; number of preintervention and postintervention points; outliers; forecasting; and absolute and/or relative changes with confidence intervals or standard errors. Additional considerations abstracted included the use of lag periods, sensitivity analysis, and graphical figures to display results. One author (R.J.) abstracted all data, and a second author (A.M.B.) verified all abstracted data. All methodological considerations were summarized using descriptive statistics.
Results
Of 1917 unique articles identified, 10 were methodological contributions [B.1e10], 4 were review articles [B.11e14], and 220 were eligible empirical applications [B.15e234] (Fig. 1 , Appendix B at www.jclinepi.com).
Each search strategy proved important, with 52 empirical applications (24%) identified solely by the keyword search, 33 (15%) identified solely by the citation search, 30 (14%) identified solely by the reference list search, and only 35 (16%) identified by all three search strategies (Fig. 2) . Most segmented regression articles (92 of 134, 69%) were identified by the citation search, whereas most ARIMA articles (26 of 31, 84%) were identified by the keyword search. One eligible article that did not appear 2 . Proportional Venn diagram of search result yield of empirical applications by search strategy, n 5 220. The size of each circle is proportional to the relative number of articles identified. MEDLINE keyword search terms are listed in Appendix A at www.jclinepi.com, and four articles were used in the Web of Science citation search [3, 5, 7, 16] . The reference search included all eligible empirical applications (n 5 189), methods (n 5 10), and reviews (n 5 4) identified by the keyword and citation searches. One article not indexed in MED-LINE or Web of Science databases was identified by a reviewer during the peer-review process [B.212].
in our original search was identified by a reviewer during the peer-review process [B.212].
The first empirical application was published in 1984, yet relatively few (n 5 17, 8%) were published before the year 2000 (Fig. 3) . Since 2000, use has increased with an average of 15 (standard deviation 5 8.2) applications published per year. Forty-one percent (n 5 90) were published in the last 4 years, with a high of 31 articles published in 2013. Table 1 summarizes the characteristics of the 220 empirical applications identified, of which 92% used administrative pharmacy databases. Drug policy changes were the most common interventions evaluated (51%), followed by new evidence (22%), safety advisories (18%), and quality improvement interventions (16%). Seventy-one percent examined prescriptions dispensed (22% number, 35%, proportion, and 14% standard dose) as the primary outcome measure, and 29% used the number or proportion of patients dispensed the drug of interest or meeting an adherence target. Most applications examined drug utilization over monthly (76%) or quarterly (14%) intervals. Of the 200 articles (91%) reporting detailed methods, segmented regression (67%), ARIMA models (16%), and linear regression (11%) were the most commonly applied analyses. Other analytical methods included generalized estimating equations, logistic, nonlinear, and Poisson models. Fifty percent (n 5 67) of articles using segmented regression applied a linear model.
Of all empirical studies, 146 (66%) reported testing for autocorrelation (77% of ARIMA articles and 73% of segmented regression articles), 68 (31%) reported adjusting for seasonality (52% of ARIMA and 29% of segmented regression), and 32 (15%) reported testing for nonstationarity (65% of ARIMA and 9% of segmented regression). One-third (35%) of all empirical studies reported the use of a comparison group, 70% reported absolute and/or relative impacts with confidence intervals or standard errors, and 28% reported including lag periods in their models. Most articles (85%) clearly reported the intervention time point(s) of interest, and 84% of studies included a graph, Fig. 3 . Number of interrupted time series empirical applications in drug utilization research, by publication year, n 5 220. yet only 39% reported the number of preintervention and postintervention data points included in their analysis (range 3e72 data points). One-fifth (21%) of applications conducted a sensitivity analysis.
Discussion
We examined the application and reporting of interrupted time series analysis methods in drug utilization research. Use of interrupted time series analysis has increased since the year 2000, a finding noted in other recent reviews of innovative methods in pharmacoepidemiology [17, 18] . The most common interrupted time series methods were segmented regression (67%), ARIMA models (16%), and linear regression (11%). When executing time series models, several methodological aspects are important and may impact the validity of the model. We identified that most eligible articles using ARI-MA models addressed autocorrelation (77%), nonstationarity (65%), and seasonality (52%). Because ARIMA models inherently account for autocorrelation, nonstationarity, and seasonality [19] , it is possible that authors may have chosen not to report these considerations. In contrast, segmented regression models do not intrinsically account for autocorrelation, nonstationarity, and seasonality, and thus, it is imperative to consider each [3] . However, only 73% of segmented regression studies reported testing for autocorrelation, 29% reported adjustment for seasonality, and only 9% reported consideration of nonstationarity.
Over 80% of interrupted time series analyses cited a clearly defined intervention time point and used figures to graphically display results; however, other methodological issues were poorly reported. Explicit reporting of all methodological considerations may improve awareness of their importance and the interpretation of interrupted time series studies. Therefore, based on prior suggestions [3e6, 12, 20] , we recommend the following be reported in all interrupted time series applications: (1) autocorrelation, nonstationarity, and seasonality considerations; (2) intervention time point(s) and lag periods; (3) the number of data points preintervention, postintervention, and between intervention(s); (4) specific statistical regression methods and the appropriateness of a linear model when applied; and (5) absolute and/or relative changes from baseline (intervention impact) with significance. We also recommend that all interrupted time series studies: (1) use a graphical display with clearly defined time point(s) to present results; (2) comment on: the minimum number of observations per data point, data variability, ceiling or floor effects; and (3) consider the use of a comparison group. Authors are also encouraged to discuss possible data or cointervention confounding issues and provide a rationale if no comparison group was considered. These recommendations are summarized in Table 2 and build from the Strengthening the Reporting of Observational Studies in Epidemiology statement [21] .
Our systematic review is subject to some limitations related to our literature search strategy and inclusion criteria. First, we recognize that the lack of Medical Subject Headings (MeSH terms) and standardized terminology to describe the interrupted time series design may have resulted in some missed applications. Although segmented regression was first introduced to health care research in 1981 [7] and a seminal method article was published in 2002 [3] , we found that many articles did not use the term ''segmented regression'' to describe their analysis. Therefore, particular attention to each study's statistical analysis was required during data abstraction to determine the type of interrupted time series method used. Second, our search was limited in ability to identify applications that are not indexed in either of the databases used (MEDLINE and Web of Science). Indeed, during the peer review of our article, a blind reviewer identified one eligible article [B.212] that is not indexed in the databases used and therefore was not identified in our original search.
Third, by restricting inclusion to studies that examined prescription drug utilization defined by the number or proportion of prescription drugs dispensed or patients dispensed a drug, we will have missed interrupted time series analyses with different drug outcomes, such as illicit drug use, drug sales, or drug market share [22, 23] . Fourth, we acknowledge that studies examining single institution interventions (n 5 59, Appendix C at www.jclinepi.com) were excluded so we could focus on population-based interventions that may be more generalizable. Despite potentially missing some applications, we feel that our results that identify an increase in the number of applications in recent years, and conclusions of the general trends of methods and underreporting of statistical considerations, would still hold. Indeed, 66% of the 59 single institution studies used segmented regression analysis, similar to our finding that 67% of studies included in our review used segmented regression analysis.
Finally, we acknowledge that our review is limited by what authors have reported or presented in their studies, which may not reflect the true methodological rigor of each study. Therefore, the large variation in reporting that we identified may not indicate inappropriate use of interrupted time series methods but rather a need for reporting standards to facilitate quality reporting, application, and interpretation of interrupted time series results.
A major strength of our systematic review is the use of multiple search strategies to identify articles. Our keyword and citation search yielded 190 eligible articles (86% overall), with only 31% identified in both. We attribute this small overlap to a lack of MeSH terms for time series analysis. The additional reference list search of eligible articles identified another 30 (14% overall) eligible applications not captured in our prior searches. This observation corroborates the importance of using multiple search strategies as identified in prior reviews of new statistical methods [17, 18] . We encourage future systematic reviews to use a similar proportional Venn diagram to clarify search strategy yield. [21] .
In summary, we identified an increase in the number of applications of interrupted time series analysis to examine interventions in drug utilization, particularly in recent years. When properly executed, interrupted time series analysis is a valuable method to evaluate the success, failure, or unintended consequences of health care interventions on drug utilization [24] . However, there is large variation in the reporting of interrupted time series methods. Developing methodological and reporting standards for interrupted time series analysis is important to improve its application in drug utilization research. We provide a summary table of methodological and reporting recommendations for researchers to consider when completing interrupted time series analyses.
